The Circadian Rhythm of Copeptin

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02604875

Acronym

Co-Rhythm

Enrollment

Registered

2015-11-16

Start date

2015-11-30

Completion date

2016-04-30

Last updated

2016-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Rhythm, Copeptin Blood Levels

Brief summary

The circadian rhythm of copeptin will be examined in healthy subjects.

Detailed description

In 18 healthy volunteers the circadian rhythm of copeptin will be examined by withdrawing blood samples for copeptin levels every 30 minutes for 24 hours.

Interventions

OTHERobservation

blood sampling during 24 hours

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* healthy subjects

Exclusion criteria

* acute illness * chronic illness * pregnancy * Anemia defined as Hb \< 30g/l

Design outcomes

Primary

Measure	Time frame	Description
measurement of copeptin values in mmol/l within 24 hours to assess the amount of release in a day curve.	24 hours	The primary outcome measure is to compare the copeptin concentration in the early afternoon and the early morning by blood sampling at different time points. Evaluation of the question if there is a circadian rhythm in the copeptin release.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026